Skip to content

FEBS Letters

ISSN 1873-3468

3 papers in the library · 11 citations · publishing 1988-2025

Papers

Sort Most recent Most cited

Molecular insights into the modulation of the 5HT2A receptor by serotonin, psilocin, and the G protein subunit Gqα.

FEBS Letters March 1, 2025 Niklas Viohl, Ali Asghar Hakami Zanjani, Himanshu Khandelia 7 citations

5HT2AR is a G-protein-coupled receptor that drives many neuronal functions and is a target for psychedelic drugs. Understanding ligand interactions and conformational transitions is essential for developing effective pharmaceuticals, but mechanistic details of 5HT2AR activation remain poorly understood. We utilized all-atom molecular dynamics simulations and free-energy calculations to...

Substrate recognition by the 4‐hydroxytryptamine kinase PsiK in psilocybin biosynthesis

FEBS Letters October 24, 2024 Kai Rogge, Tobias Wagner, Dirk Hoffmeister et al. 4 citations

Psilocybin, the natural hallucinogen from Psilocybe (magic) mushrooms, is a highly promising drug candidate for the treatment of depression and several other mental health conditions. Biosynthesis of psilocybin from the amino acid l‐ tryptophan involves four strictly sequential modifications. The third of these, ATP‐dependent phosphorylation of the intermediate 4‐hydroxytryptamine, is catalysed...

Phencyclidine and some of its analogues have distinct effects on NMDA receptors of rat hippocampal neurons.

FEBS Letters August 1, 1988 A S Ramoa, E X Albuquerque

Phencyclidine (PCP) is a dissociative anesthetic agent which blocks the excitatory effect of N-methyl-D-aspartate (NMDA) in the central nervous system. To investigate the role of the PCP reactive site in the control of NMDA activation of hippocampal pyramidal cells, we have examined the action of PCP and some of its analogues on the response properties of single NMDA receptors. Application of...